340B Drug Pricing Program Final Rule
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:appliesTo |
covered entities
drug manufacturers |
| gptkbp:citation |
gptkb:42_CFR_Part_10
|
| gptkbp:enforcedBy |
gptkb:Health_Resources_and_Services_Administration
|
| https://www.w3.org/2000/01/rdf-schema#label |
340B Drug Pricing Program Final Rule
|
| gptkbp:issuedBy |
gptkb:U.S._Department_of_Health_and_Human_Services
|
| gptkbp:legalBasis |
gptkb:340B_Drug_Pricing_Program_statute
|
| gptkbp:publishedIn |
gptkb:Federal_Register
|
| gptkbp:purpose |
clarify drug ceiling price calculation
establish manufacturer civil monetary penalties |
| gptkbp:regulates |
gptkb:340B_Drug_Pricing_Program
|
| gptkbp:startDate |
January 1, 2019
|
| gptkbp:bfsParent |
gptkb:340B_Drug_Pricing_Program
|
| gptkbp:bfsLayer |
6
|